News

In the context of ERIBA’s 10th anniversary Folkert Kuipers gave an interview to  “GROC- De Groninger Ondernemers Courant” Read the article below. In Dutch.  

Cancer cells use a high glycolytic flux for the generation of metabolic intermediates and ATP needed for cell growth and proliferation. During glycolysis NAD+ is reduced to NADH and therefore the NADH/NAD+ ratio in cancer cells is usually high. To sustain a high glycolytic flux NAD+ must be regenera

On May 2nd the article “Deletion of SERF2 in mice delays embryonic development and alters amyloid deposit structure in brain” from Ellen Nollen was published by Life Science Alliance. The article is available at https://doi.org/10.26508/lsa.202201730

12 PhD positions in the MSCA-DN Project REGENERATE-IT   Are you interested in regenerative biology? Check out our 12 fully funded PhD positions to work with leading European researchers to advance the frontiers of regenerative biology and medicine. You can find a list of all available projects

Floris Foijer has been awarded a Vici grant of 1.5 million from the netherlands Organisation for Scientific Research (NWO). With this grant, together with his team he will spend the next five years investigating how chromosomally unstable cancers evade the immune system.   https://umcgresearch.

Eugenia Goya from Ellen Nollen’s lab received a grant of € 93.174 from the Parkinson NL. Her project “Worm-Microbiomics” aims to develop a fast testing platform to study the effect of single bacterial species from the gut microbiota in C. elegans models of Parkinson’s Disease. The collec

Prof. Dr. Folkert Kuipers, Professor of Pediatrics (UMCG) and Scientific Director of ERIBA has been appointed as a member of  The Scientific Advisory Board (WAR) of Hartstichting from 1st January 2023.   https://professionals.hartstichting.nl/  

In the context of the 225 years aniversary of the UMCG, Henk Heidekamp, our Managing Director received a medal for his exceptional commitment to the five departments of wich Henk is the manager. Congratulations Henk!

‘In 80% of all cancers, cancer cells have an abnormal number of chromosomes, a state called aneuploidy. Aneuploidy discriminates cancer cells from non-cancer cells, thus making it an attractive target for cancer therapy. However, aneuploidy itself decreases the proliferation potential of healt

While most proteins neatly fold into stable structures, there are also many important proteins that are supposed to stay disordered. Disordered proteins can however be sticky and may clump together causing cellular dysfunction and, eventually, disease. An essential structure that relies disordered p